|
|
|
|
|
 |
| |
Publications
Select a time period from the list:
|
|
| |
|
|
| |
Peer-reviewed Publications for January - March 2008
|
|
|
Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL 3rd, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol. 2008 Feb 20;
|
|
|
Mukherjee O, Wang J, Gitcho M, Chakraverty S, Taylor-Reinwald L, Shears S, Kauwe JS, Norton J, Levitch D, Bigio EH, Hatanpaa KJ, White CL, Morris JC, Cairns NJ, Goate A. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Hum Mutat. 2008 Jan 8; [Epub ahead of print]
|
|
|
Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of steatohepatitis in mice fed a lipogenic methionine choline deficient (MCD) diet. J Lipid Res. 2008 Jan 28; [Epub ahead of print]
|
|
|
Fang F, Antico G, Zheng J, Clevenger CV. Quantification of PRL/Stat5 Signaling with a Novel pGL4-CISH Reporter. BMC Biotechnol. 2008 Feb 6;8(1):11 [Epub ahead of print]
|
|
|
Swaminathan G, Varghese B, Thangavel C, Carbone CJ, Plotnikov A, Kumar KG, Jablonski EM, Clevenger CV, Goffin V, Deng L, Frank SJ, Fuchs SY. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol. 2008 Feb;196(2):R1-7.
|
|
|
Clevenger CV, Zheng J, Jablonski EM, Galbaugh TL, Fang F. From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics. J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):147-56.
|
|
|
McHale K, Tomaszewski JE, Puthiyaveettil R, Livolsi VA, Clevenger CV.Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol. 2008 Feb 1; [Epub ahead of print]
|
|
|
Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, Crawford SE, Russo PA, Hammadeh R, Takahashi K, Orenstein JM. RNA-Containing Cytoplasmic Inclusion Bodies in Ciliated Bronchial Epithelium Months to Years after Acute Kawasaki Disease. PLoS ONE. 2008 Feb 13;3(2):e1582.
|
|
|
Chung C, Doll JA, Gattu AK, Shugrue C, Cornwell M, Fitchev P, Crawford SE. Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). J Hepatol. 2008 Mar;48(3):471-8.
|
|
|
Fridberg A, Olson CL, Nakayasu ES, Tyler KM, Almeida IC, Engman DM. Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei. J Cell Sci. 2008 Feb 15;121(Pt 4):522-35.
|
|
|
Bahk TJ, Daniels MD, Leon JS, Wang K, Engman DM. Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis. Int J Cardiol. 2008 Mar 28;125(1):85-93.
|
|
|
Kelemen K, Guitart J, Kuzel TM, Goolsby CL, Peterson LC. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome. Am J Clin Pathol. 2008 Jan;129(1):146-56.
|
|
|
Sodhi CP, Perez RG, Gottardi-Littell NR. Phosphorylation of beta-amyloid precursor protein (APP) cytoplasmic tail facilitates amyloidogenic processing during apoptosis. Brain Res. 2008 Mar 10;1198:204-12.
|
|
|
Godsel LM, Hobbs RP, Green KJ. Intermediate filament assembly: dynamics to disease. Trends Cell Biol. 2008 Jan;18(1):28-37. Review.
|
|
|
Haldar K, McFadden G, Young JA. Change in the editorial leadership of PLoS Pathogens. PLoS Pathog. 2008 Jan 25;4(1):e15.
. |
 |
Bhattacharjee S, van Ooij C, Balu B, Adams JH, Haldar K. Maurer's clefts of Plasmodium falciparum are secretory organelles that concentrate virulence protein reporters for delivery to the host erythrocyte. Blood. 2008 Feb 15;111(4):2418-26.
|
| |
Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood). 2008 Jan;233(1):4-11.
|
| |
Zynger DL, Dimov ND, Ho LC, Laskin WB, Yeldandi AV. Differential expression of neural-cadherin in pulmonary epithelial tumours. Histopathology. 2008 Feb;52(3):348-54.
|
| |
Robin J, Meyers S, Nahlawi M, Puthumana J, Lomasney J, Mehlman D, Rigolin V, Davidson C. Accelerating restrictive cardiomyopathy after liver transplantation in a patient with familial amyloidotic polyneuropathy: a case report. J Med Case Reports. 2008 Feb 1;2:35.
|
| |
Evens AM, Winter JN, Hou N, Nelson BP, Rademaker A, Patton D, Singhal S, Frankfurt O, Tallman MS, Rosen ST, Mehta J, Gordon LI. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma. Br J Haematol. 2008 Feb;140(4):385-93.
|
| |
Mirzoeva S, Kim ND, Chiu K, Franzen CA, Bergan RC, Pelling JC. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Mol Carcinog. 2008 Jan 31; [Epub ahead of print]
|
| |
Hawkins C, Qi C, Warren J, Stosor V. Catheter-related bloodstream infections caused by rapidly growing nontuberculous mycobacteria: a case series including rare species. Diagn Microbiol Infect Dis. 2008 Feb 20; [Epub ahead of print]
|
| |
Qi C, Malczynski M, Parker M, Scheetz MH. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J Clin Microbiol. 2008 Mar;46(3):1106-9.
|
| |
Angelotta C, McKoy JM, Fisher MJ, Buffie CG, Barfi K, Ramsey G, Frohlich L, Bennett CL. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia. Vox Sang. 2007 Aug;93(2):159-65. Review.
|
| |
Hwang H, Hou KT, Schiller CL, Wayne JD, Mendelson EB, Susnik B. Neuroendocrine carcinoma metastatic to the breast. Breast J. 2008 Mar-Apr;14(2):201-2.
|
| |
Sitterding SM, Wiseman WR, Schiller CL, Luan C, Chen F, Moyano JV, Watkin WG, Wiley EL, Cryns VL, Diaz LK. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas. Ann Diagn Pathol. 2008 Feb;12(1):33-40.
|
| |
Haines GK 3rd, Wiley E, Susnik B, Apple SK, Frkovic-Grazio S, Reyes C, Goldstein LC, Dadmanesh F, Gown AM, Nadji M, Bracko M, Tavassoli FA. HER2 in well differentiated breast cancer: is testing necessary? Breast Cancer Res Treat. 2008 Jan 18; [Epub ahead of print]
|
| |
Liao J, Seril DN, Lu GG, Zhang M, Toyokuni S, Yang AL, Yang GY. Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice. Mol Carcinog. 2008 Feb 25; [Epub ahead of print]
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
